Surgery Partners (NASDAQ:SGRY – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, November 12th. Analysts expect Surgery Partners to post earnings of $0.21 per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Surgery Partners Stock Down 0.2 %
NASDAQ:SGRY opened at $30.36 on Friday. The business’s fifty day moving average price is $31.04 and its 200 day moving average price is $28.39. The firm has a market capitalization of $3.86 billion, a price-to-earnings ratio of -112.44, a PEG ratio of 2.28 and a beta of 2.76. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96. Surgery Partners has a 1-year low of $22.25 and a 1-year high of $36.92.
Analyst Ratings Changes
Several analysts recently commented on SGRY shares. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price target for the company. Citigroup lowered their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. Macquarie reaffirmed an “outperform” rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Monday, November 4th. Finally, KeyCorp initiated coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $40.13.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Stories
- Five stocks we like better than Surgery Partners
- Most Volatile Stocks, What Investors Need to Know
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Stock Market Sectors: What Are They and How Many Are There?
- MarketBeat Week in Review – 11/4 – 11/8
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.